Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

LAMEA Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Indication (Anxiety and Depression) By Drugs, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031

Published Date : 22-Aug-2024

Pages: 134

Formats: PDF

The Latin America, Middle East and Africa Anxiety Disorders And Depression Treatment Market would witness market growth of 5.8% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Anxiety Disorders And Depression Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $316.1 million by 2031. The Argentina market is showcasing a CAGR of 6.5% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 5.1% during (2024 - 2031).

LAMEA Anxiety Disorders And Depression Treatment Market

Innovations in the treatment of anxiety disorders and depression are continually evolving to address the complex nature of these conditions. Advances in technology, research, and therapeutic approaches are driving significant improvements in how these mental health issues are managed.

Moreover, medications like ketamine and its derivative ketamine have emerged as rapid-acting antidepressants, offering relief from severe depression within hours or days rather than weeks. These treatments are particularly beneficial for individuals with treatment-resistant depression.

With growing mental health issues among children, there’s a rising demand for specialized treatment services. This includes increased utilization of paediatric mental health professionals, child psychologists, and psychiatrists in the UAE. Depressive symptoms are experienced by approximately 17% to 22% of young people in the United Arab Emirates, as indicated by the International Health Policies. Depression and anxiety symptoms are reported by up to one-third of children with chronic disorders.

Free Valuable Insights: The Worldwide Anxiety Disorders And Depression Treatment Market is Projected to reach USD 15.7 Billion by 2031, at a CAGR of 3.5%

Based on Indication, the market is segmented into Anxiety and Depression. Based on Drugs, the market is segmented into Antidepressants, Anxiolytics, Anticonvulsants, Noradrenergic Agents, and Atypical Antipsychotics. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Pfizer Inc.
  • GlaxoSmithKline PLC (GSK)
  • Merck & Co., Inc.
  • Eli Lilly And Company
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Johnson & Johnson
  • AbbVie Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited

LAMEA Anxiety Disorders And Depression Treatment Market Report Segmentation

By Indication

  • Anxiety
  • Depression

By Drugs

  • Antidepressants
  • Anxiolytics
  • Anticonvulsants
  • Noradrenergic Agents
  • Atypical Antipsychotics

By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Anxiety Disorders And Depression Treatment Market, by Indication
1.4.2 LAMEA Anxiety Disorders And Depression Treatment Market, by Drugs
1.4.3 LAMEA Anxiety Disorders And Depression Treatment Market, by Distribution Channel
1.4.4 LAMEA Anxiety Disorders And Depression Treatment Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. LAMEA Anxiety Disorders And Depression Treatment Market by Indication
4.1 LAMEA Anxiety Market by Country
4.2 LAMEA Depression Market by Country

Chapter 5. LAMEA Anxiety Disorders And Depression Treatment Market by Drugs
5.1 LAMEA Antidepressants Market by Country
5.2 LAMEA Anxiolytics Market by Country
5.3 LAMEA Anticonvulsants Market by Country
5.4 LAMEA Noradrenergic Agents Market by Country
5.5 LAMEA Atypical Antipsychotics Market by Country

Chapter 6. LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel
6.1 LAMEA Retail Pharmacies Market by Country
6.2 LAMEA Hospital Pharmacies Market by Country
6.3 LAMEA Online Pharmacies Market by Country

Chapter 7. LAMEA Anxiety Disorders And Depression Treatment Market by Country
7.1 Brazil Anxiety Disorders And Depression Treatment Market
7.1.1 Brazil Anxiety Disorders And Depression Treatment Market by Indication
7.1.2 Brazil Anxiety Disorders And Depression Treatment Market by Drugs
7.1.3 Brazil Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.2 Argentina Anxiety Disorders And Depression Treatment Market
7.2.1 Argentina Anxiety Disorders And Depression Treatment Market by Indication
7.2.2 Argentina Anxiety Disorders And Depression Treatment Market by Drugs
7.2.3 Argentina Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.3 UAE Anxiety Disorders And Depression Treatment Market
7.3.1 UAE Anxiety Disorders And Depression Treatment Market by Indication
7.3.2 UAE Anxiety Disorders And Depression Treatment Market by Drugs
7.3.3 UAE Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.4 Saudi Arabia Anxiety Disorders And Depression Treatment Market
7.4.1 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Indication
7.4.2 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Drugs
7.4.3 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.5 South Africa Anxiety Disorders And Depression Treatment Market
7.5.1 South Africa Anxiety Disorders And Depression Treatment Market by Indication
7.5.2 South Africa Anxiety Disorders And Depression Treatment Market by Drugs
7.5.3 South Africa Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.6 Nigeria Anxiety Disorders And Depression Treatment Market
7.6.1 Nigeria Anxiety Disorders And Depression Treatment Market by Indication
7.6.2 Nigeria Anxiety Disorders And Depression Treatment Market by Drugs
7.6.3 Nigeria Anxiety Disorders And Depression Treatment Market by Distribution Channel
7.7 Rest of LAMEA Anxiety Disorders And Depression Treatment Market
7.7.1 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Indication
7.7.2 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Drugs
7.7.3 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Pfizer, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 GlaxoSmithKline PLC (GSK)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Merck & Co., Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Eli Lilly And Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 AstraZeneca PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Bristol-Myers Squibb Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 Johnson & Johnson
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental & Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 AbbVie, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Sanofi S.A.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Takeda Pharmaceutical Company Limited
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
TABLE 1 LAMEA Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 3 LAMEA Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 4 LAMEA Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 5 LAMEA Anxiety Market by Country, 2020 - 2023, USD Million
TABLE 6 LAMEA Anxiety Market by Country, 2024 - 2031, USD Million
TABLE 7 LAMEA Depression Market by Country, 2020 - 2023, USD Million
TABLE 8 LAMEA Depression Market by Country, 2024 - 2031, USD Million
TABLE 9 LAMEA Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 10 LAMEA Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 11 LAMEA Antidepressants Market by Country, 2020 - 2023, USD Million
TABLE 12 LAMEA Antidepressants Market by Country, 2024 - 2031, USD Million
TABLE 13 LAMEA Anxiolytics Market by Country, 2020 - 2023, USD Million
TABLE 14 LAMEA Anxiolytics Market by Country, 2024 - 2031, USD Million
TABLE 15 LAMEA Anticonvulsants Market by Country, 2020 - 2023, USD Million
TABLE 16 LAMEA Anticonvulsants Market by Country, 2024 - 2031, USD Million
TABLE 17 LAMEA Noradrenergic Agents Market by Country, 2020 - 2023, USD Million
TABLE 18 LAMEA Noradrenergic Agents Market by Country, 2024 - 2031, USD Million
TABLE 19 LAMEA Atypical Antipsychotics Market by Country, 2020 - 2023, USD Million
TABLE 20 LAMEA Atypical Antipsychotics Market by Country, 2024 - 2031, USD Million
TABLE 21 LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 22 LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 23 LAMEA Retail Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 24 LAMEA Retail Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 25 LAMEA Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 26 LAMEA Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 27 LAMEA Online Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 28 LAMEA Online Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 29 LAMEA Anxiety Disorders And Depression Treatment Market by Country, 2020 - 2023, USD Million
TABLE 30 LAMEA Anxiety Disorders And Depression Treatment Market by Country, 2024 - 2031, USD Million
TABLE 31 Brazil Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 32 Brazil Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 33 Brazil Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 34 Brazil Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 35 Brazil Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 36 Brazil Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 37 Brazil Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 38 Brazil Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 39 Argentina Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 40 Argentina Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 41 Argentina Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 42 Argentina Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 43 Argentina Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 44 Argentina Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 45 Argentina Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 46 Argentina Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 47 UAE Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 48 UAE Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 49 UAE Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 50 UAE Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 51 UAE Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 52 UAE Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 53 UAE Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 54 UAE Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 55 Saudi Arabia Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 56 Saudi Arabia Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 57 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 58 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 59 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 60 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 61 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 62 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 63 South Africa Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 64 South Africa Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 65 South Africa Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 66 South Africa Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 67 South Africa Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 68 South Africa Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 69 South Africa Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 70 South Africa Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 71 Nigeria Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 72 Nigeria Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 73 Nigeria Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 74 Nigeria Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 75 Nigeria Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 76 Nigeria Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 77 Nigeria Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 78 Nigeria Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 79 Rest of LAMEA Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
TABLE 80 Rest of LAMEA Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
TABLE 81 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
TABLE 82 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
TABLE 83 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
TABLE 84 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
TABLE 85 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 86 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 87 Key Information – Pfizer, Inc.
TABLE 88 Key Information – GlaxoSmithKline PLC
TABLE 89 Key Information - Merck & Co., Inc.
TABLE 90 Key Information – Eli Lilly And Company
TABLE 91 Key Information – AstraZeneca PLC
TABLE 92 Key Information – Bristol-Myers Squibb Company
TABLE 93 Key Information – Johnson & Johnson
TABLE 94 Key information – AbbVie, Inc.
TABLE 95 Key Information – Sanofi S.A.
TABLE 96 Key Information – Takeda Pharmaceutical Company Limited

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Anxiety Disorders And Depression Treatment Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Anxiety Disorders And Depression Treatment Market
FIG 4 Porter’s Five Forces Analysis – Anxiety Disorders And Depression Treatment Market
FIG 5 LAMEA Anxiety Disorders And Depression Treatment Market share by Indication, 2023
FIG 6 LAMEA Anxiety Disorders And Depression Treatment Market share by Indication, 2031
FIG 7 LAMEA Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2031, USD Million
FIG 8 LAMEA Anxiety Disorders And Depression Treatment Market share by Drugs, 2023
FIG 9 LAMEA Anxiety Disorders And Depression Treatment Market share by Drugs, 2031
FIG 10 LAMEA Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2031, USD Million
FIG 11 LAMEA Anxiety Disorders And Depression Treatment Market share by Distribution Channel, 2023
FIG 12 LAMEA Anxiety Disorders And Depression Treatment Market share by Distribution Channel, 2031
FIG 13 LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2031, USD Million
FIG 14 LAMEA Anxiety Disorders And Depression Treatment Market share by Country, 2023
FIG 15 LAMEA Anxiety Disorders And Depression Treatment Market share by Country, 2031
FIG 16 LAMEA Anxiety Disorders And Depression Treatment Market by Country, 2020 - 2031, USD Million
FIG 17 SWOT Analysis: Pfizer, Inc.
FIG 18 SWOT Analysis: GlaxoSmithKline PLC
FIG 19 SWOT Analysis: Merck & Co., Inc.
FIG 20 Swot Analysis: Eli Lilly And Company
FIG 21 SWOT Analysis: AstraZeneca PLC
FIG 22 SWOT Analysis: Bristol-Myers Squibb Company
FIG 23 SWOT Analysis: Johnson & Johnson
FIG 24 Swot Analysis: AbbVie, Inc.
FIG 25 Swot Analysis: Sanofi S.A.
FIG 26 SWOT Analysis:Takeda Pharmaceutical Company Limited

Purchase Full Report of
LAMEA Anxiety Disorders And Depression Treatment Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL